Company Overview
About Opentrons
Opentrons Labworks is a New York-based life sciences company that designs and manufactures affordable, open-source liquid-handling robots for research laboratories. Founded in 2014, Opentrons'' mission is to democratize biology by making advanced lab automation accessible to life scientists at any institution — from academic labs with limited budgets to leading pharmaceutical companies. Its flagship products, the OT-2 and the newer Opentrons Flex, are programmable robotic platforms that automate repetitive liquid-handling tasks such as PCR setup, nucleic acid extraction, ELISA assays, and next-generation sequencing sample preparation.
Business Model & Competitive Advantage
With more than 10,000 robotic systems deployed worldwide, Opentrons has become one of the most widely adopted liquid-handling automation platforms in life sciences. The company has raised over $200 million in total funding, including a $20.1M Series C extension in November 2025. In July 2025, James Atwood was promoted to Chief Executive Officer. Strategic partnerships have accelerated in 2025–2026: BD (Becton, Dickinson) and Opentrons announced a multi-year collaboration in October 2025 to integrate Flex robotic capabilities into BD single-cell multiomics instruments. In February 2026, HighRes and Opentrons announced the industry''s first AI agent-to-agent laboratory automation workflow, connecting autonomous AI agents to physical lab operations.
Competitive Landscape 2025–2026
Opentrons'' open-source software ecosystem and Python-based protocol library allow researchers to write, share, and reuse automation protocols, lowering the barrier to robotic lab adoption. This community-first model drives viral adoption across research institutions. As life science workflows increasingly demand reproducibility, throughput, and AI-driven data generation, Opentrons is positioned at the intersection of lab automation and the emerging lab-of-the-future paradigm, competing with larger incumbents like Hamilton, Tecan, and Beckman Coulter.
Key Differentiators
Market Leader
Opentrons is recognized as a market leader in the Life Sciences & BioTech sector, demonstrating strong industry presence and customer trust.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
Saluda Medical
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Schrödinger
Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has develo
Compare Opentrons with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Opentrons? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Opentrons Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Opentrons vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →